Gregory B. Melikyan

5.0k total citations · 1 hit paper
77 papers, 3.7k citations indexed

About

Gregory B. Melikyan is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Gregory B. Melikyan has authored 77 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Virology, 36 papers in Infectious Diseases and 23 papers in Epidemiology. Recurrent topics in Gregory B. Melikyan's work include HIV Research and Treatment (58 papers), HIV/AIDS drug development and treatment (27 papers) and Immune Cell Function and Interaction (11 papers). Gregory B. Melikyan is often cited by papers focused on HIV Research and Treatment (58 papers), HIV/AIDS drug development and treatment (27 papers) and Immune Cell Function and Interaction (11 papers). Gregory B. Melikyan collaborates with scholars based in United States, Japan and Germany. Gregory B. Melikyan's co-authors include Mariana Marin, Ashwanth C. Francis, Kosuke Miyauchi, Olga Latinovic, Yuri Kim, Vladimir A. Morozov, Tanay M. Desai, N Kondo, Abraham L. Brass and George Savidis and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Gregory B. Melikyan

75 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HIV Enters Cells via Endocytosis and Dynamin-Dependent Fusion with Endosomes

2009 524 citations Kosuke Miyauchi, Yuri Kim et al. Cell profile →

Peers

Countries citing papers authored by Gregory B. Melikyan

Since Specialization

Citations

This map shows the geographic impact of Gregory B. Melikyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory B. Melikyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory B. Melikyan more than expected).

Fields of papers citing papers by Gregory B. Melikyan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory B. Melikyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory B. Melikyan. The network helps show where Gregory B. Melikyan may publish in the future.

Co-authorship network of co-authors of Gregory B. Melikyan

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory B. Melikyan. A scholar is included among the top collaborators of Gregory B. Melikyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory B. Melikyan. Gregory B. Melikyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structural, biophysical, and virological mechanistic characterization of HIV-1 capsid-targeting antivirals 2025 ·bioRxiv (Cold Spring Harbor Laboratory) ·Karen A. Kirby, (unknown), (unknown), (unknown), Hu Zhang, (unknown), (unknown), (unknown), (unknown), Atsuko Hachiya, (unknown), (unknown), (unknown), (unknown), Philip R. Tedbury, Ashwanth C. Francis, Gregory B. Melikyan, (unknown), (unknown), (unknown), (unknown)	0
2	Attenuation of IFITM proteins’ antiviral activity through sequestration into intraluminal vesicles of late endosomes 2025 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), Gregory B. Melikyan	0
3	Influenza D virus utilizes both 9- O -acetylated N -acetylneuraminic and 9- O -acetylated N -glycolylneuraminic acids as functional entry receptors 2024 ·Journal of Virology ·(unknown), Jieshi Yu, Aitor Nogales, (unknown), Hai Yu, Xi Chen, Yunpeng Liu, Andrew S. Bowman, Luis Martínez‐Sobrido, Colin R. Parrish, Gregory B. Melikyan, Dan Wang, Feng Li	4
4	Multidisciplinary studies with mutated HIV-1 capsid proteins reveal structural mechanisms of lattice stabilization 2023 ·Nature Communications ·A.T. Gres, Karen A. Kirby, (unknown), Haijuan Du, Dandan Liu, Chaoyi Xu, (unknown), Juan R. Perilla, Jiong Shi, Christopher Aiken, (unknown), Peijun Zhang, Ashwanth C. Francis, Gregory B. Melikyan, Stefan G. Sarafianos	11
5	Cyclosporines Antagonize the Antiviral Activity of IFITMProteins by Redistributing Them toward the Golgi Apparatus 2023 ·Biomolecules ·(unknown), Mariana Marin, Tanay M. Desai, Yuhong Du, Haian Fu, Gregory B. Melikyan	2
6	Prion-like low complexity regions enable avid virus-host interactions during HIV-1 infection 2022 ·Nature Communications ·Guochao Wei, (unknown), Valentine V. Courouble, Ashwanth C. Francis, Parmit K. Singh, Arpa Hudait, Arun S. Annamalai, S.M. Bester, Szu‐Wei Huang, Nikoloz Shkriabai, (unknown), (unknown), Vineet N. KewalRamani, Gregory A. Voth, Alan Engelman, Gregory B. Melikyan, Patrick R. Griffin, Francisco J. Asturias, Mamuka Kvaratskhelia	32
7	SERINC5-Mediated Restriction of HIV-1 Infectivity Correlates with Resistance to Cholesterol Extraction but Not with Lipid Order of Viral Membrane 2022 ·Viruses ·(unknown), Yen-Cheng Chen, Mariana Marin, Hui Wu, Gregory B. Melikyan	5
8	Human LAMP1 accelerates Lassa virus fusion and potently promotes fusion pore dilation upon forcing viral fusion with non-endosomal membrane 2022 ·PLoS Pathogens ·(unknown), Juan Carlos de la Torre, Gregory B. Melikyan	12
9	The late endosome-resident lipid bis(monoacylglycero)phosphate is a cofactor for Lassa virus fusion 2021 ·PLoS Pathogens ·Ruben M. Markosyan, Mariana Marin, (unknown), Fredric S. Cohen, Gregory B. Melikyan	20
10	Structural and mechanistic bases for a potent HIV-1 capsid inhibitor 2020 ·Science ·S.M. Bester, Guochao Wei, Haiyan Zhao, Daniel Adu‐Ampratwum, (unknown), Valentine V. Courouble, Ashwanth C. Francis, Arun S. Annamalai, Parmit K. Singh, Nikoloz Shkriabai, (unknown), James H. Morrison, Eric M. Poeschla, Alan Engelman, Gregory B. Melikyan, Patrick R. Griffin, James R. Fuchs, Francisco J. Asturias, Mamuka Kvaratskhelia	159
11	HIV-1 replication complexes accumulate in nuclear speckles and integrate into speckle-associated genomic domains 2020 ·Nature Communications ·Ashwanth C. Francis, Mariana Marin, Parmit K. Singh, Vasudevan Achuthan, (unknown), (unknown), Shuiyun Lan, Philip R. Tedbury, Stefan G. Sarafianos, Alan Engelman, Gregory B. Melikyan	113
12	Screening and Functional Profiling of Small-Molecule HIV-1 Entry and Fusion Inhibitors 2017 ·Assay and Drug Development Technologies ·Charline Giroud, Yuhong Du, Mariana Marin, (unknown), Nathan T. Jui, Haian Fu, Gregory B. Melikyan	5
13	An improved labeling strategy enables automated detection of single-virus fusion and assessment of HIV-1 protease activity in single virions 2017 ·Journal of Biological Chemistry ·(unknown), Ashwanth C. Francis, Tanay M. Desai, Gregory B. Melikyan	20
14	Siglec-1 initiates formation of the virus-containing compartment and enhances macrophage-to-T cell transmission of HIV-1 2017 ·PLoS Pathogens ·J. Hammonds, Neal Beeman, Lingmei Ding, (unknown), Ashwanth C. Francis, Jaang-Jiun Wang, Gregory B. Melikyan, Paul Spearman	72
15	How entry inhibitors synergize to fight HIV 2017 ·Journal of Biological Chemistry ·Gregory B. Melikyan	9
16	High-Throughput HIV–Cell Fusion Assay for Discovery of Virus Entry Inhibitors 2015 ·Assay and Drug Development Technologies ·Mariana Marin, Yuhong Du, Charline Giroud, Jeong Hwa Kim, Min Qui, Haian Fu, Gregory B. Melikyan	27
17	Fusion of Mature HIV-1 Particles Leads to Complete Release of a Gag-GFP-Based Content Marker and Raises the Intraviral pH 2013 ·PLoS ONE ·Sergi Padilla‐Parra, Mariana Marin, (unknown), Rolf Suter, N Kondo, Gregory B. Melikyan	44
18	Multifaceted Mechanisms of HIV-1 Entry Inhibition by Human α-Defensin 2012 ·Journal of Biological Chemistry ·Lusine Demirkhanyan, Mariana Marin, Sergi Padilla‐Parra, Changyou Zhan, Kosuke Miyauchi, (unknown), Gennadiy Novitskiy, Wuyuan Lu, Gregory B. Melikyan	72
19	HIV Enters Cells via Endocytosis and Dynamin-Dependent Fusion with Endosomes breakdown → 2009 ·Cell ·Kosuke Miyauchi, Yuri Kim, Olga Latinovic, Vladimir A. Morozov, Gregory B. Melikyan	524
20	Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm 2008 ·Retrovirology ·Gregory B. Melikyan	136

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact